Analysts Positive On BioLineRx Ltd. Following Ph2 Testing Expansion For AML
May 05, 2015 at 08:55 AM EDT
On May 4, BioLineRx announced the expansion stage of the Phase 2 clinical trial for BL-8040, a drug for acute myeloid leukemia, or AML. Top-line results will be announced in the fourth quarter of this year.